The anti-tumor effect of arctigenin was associated with its dual actions on both tumor itself to control dysregulated tumor signaling like AR and Nkx3.1 and on adipose tissues to reduce the secretion of pro-cancer adipokines/cytokines as well as the release of free fatty acid. The gene discussed is NKX3-1; the disease is cancer.